TrialHead & neck2022

Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor.

Paul L Swiecicki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.